A phase 2 human challenge trial will measure time to recovery from dengue and determine effective doses of the monoclonal antibody. There are currently no therapeutics for dengue virus infection.

Children who experience multiple cases of dengue virus develop an army of dengue-fighting T cells, according to a new study led by scientists at La Jolla Institute for Immunology (LJI). The ...

Dengue is the most common arboviral disease ... To enhance the assay's accuracy in detecting antibodies in the blood of previously infected people (even those without apparent symptoms), the ...

As dengue cases rise, an infectious disease expert ... "Majority, mga bata pa rin ang vulnerable nito dahil wala pa silang antibody. Hindi pa sila na-expose before sa ganitong klaseng kaso ...

These children, ages 2 to 17, come in for regular blood draws to test for antibodies against dengue virus. By detecting a rise in these antibodies, compared to the previous year, researchers can ...